AzTrials
AzTrials

Sick LeaveNCT05772494

Assessment of Activity Limitations, a Basis for Understanding the Need for Sickness Certificate and Rehabilitation

A study testing Assessment of activity limitations, SDO and DOA in people with Sick Leave, run by Göteborg University at 1 site in Sweden.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

In Sweden mental disorders have the highest proportion of sickness absence and sickness spells. One cause for this is proposed as the lack of knowledge on which activity limitations that have an impact on the ability to return to work. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Sick Leave
What is being tested?
Assessment of activity limitations, SDO and DOA
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
1 siteSweden
Study dates
3 Apr 2023to Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • All patients registered at the chosen psychiatric care centers, in need for their second or third sickness certificate within the unit.

Who cannot join

  • Patients with specific diagnosis belonging to another unit within the psychiatric organization.
  • Patients assessed as being in an acute vulnerable situation where the planned intervention could negatively influence the situation e.g. having suicidal thoughts, or having such language difficulties that an interpreter is needed (which could complicate the understanding of the meaning of the intervention and cause unnecessary worries).

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Göteborg University, Institute of Neuroscience and Physiology

    Gothenburg, 40530

Other trials in Sweden

About this study

Official title: Early Assessment of Activity Limitations, a Basis for Understanding the Need for Sickness Certificate and Rehabilitation. A Randomized Controlled Study of People With Mental Disorders in Specialized Psychiatric Care

In Sweden mental disorders have the highest proportion of sickness absence and sickness spells. One cause for this is proposed as the lack of knowledge on which activity limitations that have an impact on the ability to return to work. Further, there is a knowledge gap concerning the effect of which early measures from the health system, assessments and early rehabilitation interventions, that enables return to work. Such early measures have been proposed to have a more multidimensional perspective, than to solely focus on specific tasks during a work situation.

The aim of the current project is to examine the effect of an early assessment of activity limitations, made by occupational therapists within specialized psychiatric care, at the time for the next prolonged sickness certification. The assessment will be included in the sickness certificate, and results will be compared between the intervention group and a control group. The results are calculated for differences on treatment measures, prevalence of questions from the Social Insurance Agency and changes in the patterns for sick leave spells. Further, the prevalence of activity limitations and the sick listed participants assessments of the effect of the intervention will be presented.

The results are expected to lead to more adequate interventions for the individual regarding support to return to work, better routines for assessment and rehabilitation within the health care system, which in turn can facilitate decisions for sickness benefits and further have an impact on the long sick leave spells concerning mental disorders.

Read the detailed description

Several individuals diagnosed with mental health disorders get sick-listed, and further, stay within the sick-leave process for a prolonged period. More research has been warranted both concerning how to assess activity limitations and future work capacity when having a psychiatric diagnose, but also when it comes to find suitable measures for supporting individuals to return to work. Such supportive and rehabilitative measures could be situated within the healthcare system, such as specialized psychiatric care. To conduct these measures, both early assessments as well as investigation of the effect of taken measures are needed. The present study concerns an expanded assessment of activity limitations as a basis for possible interventions with a focus on the individuals sick-leave process.

The understanding of work capacity has been proposed as a complex phenomenon, where several perspectives are needed. The contribution from occupational therapist in the teamwork implies being focussed on activity limitations or facilitators in contrast to solely focussing on body functions or symptoms. In the professional vocabular, activities are named occupations, meaning that the actual performance is influenced both by individual experiences and influenced by factors in the environment. Another assumption is that all everyday life occupations are interacting, and thus could have an impact on work capacity.

The purpose with this randomized, controlled trial is to evaluate if an early and expanded assessment made by occupational therapist, and with the use of two validated instruments A Dialogue About Ability Related to Work (DOA) and Satisfaction with Daily Occupations (SDO), can have an impact on choice of interventions, changes in the patterns for sick leave spells as well as prevalence of questions from the Social Insurance Agency (SIA) and the participators evaluation of effects from being part of the project. The chosen instruments are described as complementing each other, where DOA examines an overall summary of prerequisites for work capacity, and SDO adds a broader understanding of a person's occupations in everyday life, including satisfaction and balance between different occupational arenas such as work, un-paid work, leisure etc.

The project will be carried out in specialized, psychiatric teams within the Region Västra Götaland. The aim is to recruit 150 participants (75 to the intervention group and 75 to the control group). The participants will be randomly and consecutively divided into intervention or control group. Inclusion criteria are all patients registered at the chosen psychiatric care centres, in need for their second sickness certificate within the unit. Exclusion criteria are patients with specific diagnosis belonging to another unit within the psychiatric organization, and if the patient is assessed as being in an acute vulnerable situation where the planned intervention could negatively influence the situation. Register follow-ups on health care treatment, sick-leave spells, questions from SIA will be made 6 and 12 months later. The participant questionnaire will be sent 6 months after the intervention. Four studies are planned to evaluate the intervention.

The study is a collaborative project involving Region Västra Götaland. The research team comprise researchers from Göteborg University (C Andersson and K Holmgren) and from Region Västra Götaland (C Melin). The study has been submitted to the Regional Ethical Review Board.

Conditions
Sick Leave
Being tested
Assessment of activity limitations, SDO and DOA, Control group
Keywords
Sick leave, Mental disorders, Occupational Therapy, Activity limitations
Medical subject headings
Mental Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Assessment of activity limitations, SDO and DOAOther

    Also called Satisfaction with Daily Occupations (SDO), A Dialogue About Ability Realted to Work (DOA)

    The assessment is made with two instruments (DOA, SDO), and finally the occupational therapist includes the analysis and summary of activity limitations to the sickness certificate. For comparative reasons the participant will answer to a sociodemographic questionnaire focusing on work situation and sick leave

  • Control groupOther

    All assessments concerning activity limitations are made using usual routines, primarily by the sick-listing physician. For comparative reasons the participant will answer to a sociodemographic questionnaire focusing on work situation and sick leave

Study groups in NCT05772494
Study groupRoleWhat they receive
Assessment of activity limitationExperimentalAssessment and analysis of activity limitation by occupational therapist using 2 registered instruments (SDO and DOA).
Receives: Other: Assessment of activity limitations, SDO and DOA
Control group: treatment as usualActive comparatorAssessment of activity limitations according to usual routines
Receives: Other: Control group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Health care treatments

    Differences in types of healthcare treatment options between intervention and control group. Comparisons will be made between intervention and control group with regard to registered codes for intervention and codes for professionals responsible for treatment options. Descriptive calculations and comparisons will be made on differences in types of as well as changes in treatment measures within the notified time frame.

    Measured: 6 months after inclusion

  2. Changes in sick leave patterns

    Differences in number of sick leave periods, full-time or part-time or number of sick leave spells between intervention and control group.

    Measured: 6 months after inclusion

  3. Number of questions from the Social Insurance Agency (SIA)

    Differences in number of clarifying questions from SIA between intervention and control group.

    Measured: 6 months after inclusion

Secondary outcomes (1)
  1. Participants self-assessed effects of being part of the project

    Data is gathered by a structured questionnaire covering experiences of treatment, support, and effects on need for sick leave after inclusion. Differences in experiences between intervention and control group will be measured. Questions asked are constructed as multiple choice questions, on an ordinal scale, about being on prolonged sick leave, length of sick leave period, having returned to work or not. Questions are further asked about opinions on the effect of treatment on work ability, support for following steps in vocational rehabilitation and contact with other stakeholders within the work rehabilitation process. These latter questions are answered with a 5-point Likert scale, where 1 is "do not agree" and 5 is "fully agreeing".

    Measured: 6 months after inclusion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Mar 2023
  2. Study start3 Apr 2023
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
The participants are consecutively assigned to either intervention or control group depending on the time for the next prolonged sick leave period. Participants in the intervention group are invited to an assessment session with an occupational therapist focusing on limitations and enablers in activities related to pre-requisites for returning to work. Participants in the control group receive assessments for sickness certificate according to ordinary routines.
Masking
None (open label)
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05772494
Sponsor's protocol ID
FK 2022/012285
Status last verified
May 2026
First submitted
1 Mar 2023
Last updated
6 May 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Assessment of activity limitations, SDO and DOA in people with Sick Leave, run by Göteborg University at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 6 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Health care treatments (time frame: 6 months after inclusion). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in